HEMOLYTIC-ANEMIAS - DIAGNOSIS AND MANAGEMENT

被引:70
|
作者
TABBARA, IA
机构
[1] Bone Marrow Transplantation Program, Ross Hall, George Washington Univ. Med. Center, Washington, DC 20037, 2300 Eye Street, NW
关键词
D O I
10.1016/S0025-7125(16)30345-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hemolysis can be induced by two general mechanisms. In the first one, erythrocytes lyse intravascularly due to complement fixation, trauma, or other extrinsic factors. In the second mechanism, which is the most common, the red cells are removed from the circulation by the mononuclear-phagocytic system either because they are intrinsically defective or because of the presence of bound immunoglobulins to their surfaces. The diagnosis of hemolysis is not difficult to establish and is based on the presence of anemia with sustained reticulocytosis in the absence of blood loss. Additional findings can include marrow erythroid hyperplasia; increased unconjugated bilirubin, LDH, and free hemoglobin; decreased haptoglobin and hemopexin; hemoglobinuria and hemosiderinuria; and decreased 51Cr red cell half-life. Hemoglobinemia, hemoglobinuria, and hemosiderinuria occur only in the setting of severe and rapid intravascular hemolysis. Conditions associated with significant lysis of red cells in the circulation include incompatible transfusion, G6PD deficiency, PNH, severe burns, and certain infections. The morphology of the red cell is abnormal in almost all cases of hemolytic anemia. However, the morphologic abnormality can be, in certain cases, diagnostic of the underlying condition. Treatment is usually supportive, with effective therapy directed to treat the underlying cause of hemolysis.
引用
收藏
页码:649 / 668
页数:20
相关论文
共 50 条
  • [41] HEMOLYTIC-ANEMIAS ASSOCIATED WITH DEFICIENT OR DYSFUNCTIONAL SPECTRIN
    LUX, SE
    PEASE, B
    TOMASELLI, MB
    JOHN, KM
    BERNSTEIN, S
    JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1978, : 194 - 194
  • [42] LABORATORY INVESTIGATION OF HEMOLYTIC-ANEMIAS .2.
    SOTELOAVILA, C
    GOOCH, WM
    JOURNAL OF THE TENNESSEE MEDICAL ASSOCIATION, 1977, 70 (09): : 655 - 656
  • [43] Diagnosis and Management of Autoimmune Hemolytic Anemias
    Barcellini, Wilma
    Fattizzo, Bruno
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (20)
  • [44] CONGENITAL NON-SPHEROCYTIC HEMOLYTIC-ANEMIAS
    ZANELLA, A
    COLOMBO, MB
    ROSSI, F
    MERATI, G
    SIRCHIA, G
    HAEMATOLOGICA, 1989, 74 (04) : 387 - 396
  • [45] DRUG-INDUCED IMMUNE HEMOLYTIC-ANEMIAS
    HABIBI, B
    SEMAINE DES HOPITAUX, 1989, 65 (42): : 2599 - 2607
  • [46] RHEOLOGY OF ERYTHROCYTES AND SPLENECTOMY IN CONGENITAL HEMOLYTIC-ANEMIAS
    TILLMANN, W
    SCHROTER, W
    MONATSSCHRIFT KINDERHEILKUNDE, 1982, 130 (05) : 254 - 266
  • [47] DRUG-INDUCED IMMUNE HEMOLYTIC-ANEMIAS
    HABIBI, B
    PATHOLOGIE BIOLOGIE, 1988, 36 (10): : 1237 - 1245
  • [48] NOMIFENSIN-INDUCED IMMUNE HEMOLYTIC-ANEMIAS
    ECKSTEIN, R
    RIESS, H
    SAUER, H
    MEMPEL, W
    KLINISCHE WOCHENSCHRIFT, 1981, 59 (11): : 567 - 569
  • [49] THE MECHANISM OF SEVERAL EXPERIMENTAL HEMOLYTIC-ANEMIAS IN RATS
    ONODERA, T
    AKAHANE, K
    FURUHAMA, K
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1986, 9 (08): : S93 - S93
  • [50] HEMOLYTIC-ANEMIAS DURING PREGNANCY AND REPRODUCTIVE YEARS
    MINTZ, U
    MOOHR, JW
    ULTMANN, JE
    JOURNAL OF REPRODUCTIVE MEDICINE, 1977, 19 (05) : 243 - 253